The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine (ALC) in treatment of chemotherapy-induced peripheral neuropathy (CPIN).
Yuanjue Sun
No relevant relationships to disclose
Baorui Liu
No relevant relationships to disclose
Ping Liu
No relevant relationships to disclose
Changping Wu
No relevant relationships to disclose
Rongsheng Zheng
No relevant relationships to disclose
Xiaohua Zhang
No relevant relationships to disclose
Zhixiang Zhuang
No relevant relationships to disclose
Yongchuan Deng
No relevant relationships to disclose
Leizhen Zheng
No relevant relationships to disclose
Qing Xu
No relevant relationships to disclose
Bin Jiang
No relevant relationships to disclose
Xuenong Ouyang
No relevant relationships to disclose
Jianfei Gao
No relevant relationships to disclose
Su Jiang
No relevant relationships to disclose
Wei Zheng
No relevant relationships to disclose
Benjamin Xiaoyi Li
No relevant relationships to disclose
Yongqian Shu
No relevant relationships to disclose
Yang Yao
No relevant relationships to disclose